These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23441455)

  • 21. [Results of treatment for male prolactinomas].
    Iwai Y; Yamanaka K; Ishiguro T; Morikawa T; Matsuzaka Y; Komiyama M; Yasui T
    No Shinkei Geka; 2002 Dec; 30(12):1285-92. PubMed ID: 12491580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of bromocriptine on the treatment of prolactinomas in male patients and its influences on their sexual function].
    Xue XC; Jiang S; Yin SL; Zhong CH; Zhou PZ; Cheng SW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 May; 44(3):452-7. PubMed ID: 23898534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impotence as a presenting symptom of presumed prolactinoma in a patient with diabetes mellitus.
    Shakir KM
    Diabetes Care; 1983; 6(5):510-1. PubMed ID: 6336347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Giant invasive prolactinoma: a case report and review of nine further cases.
    Davis JR; Sheppard MC; Heath DA
    Q J Med; 1990 Mar; 74(275):227-38. PubMed ID: 2385731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First reported pediatric case of systemic lupus erythematosus associated with prolactinoma.
    Reuman PD
    Arthritis Rheum; 2004 Nov; 50(11):3616-8. PubMed ID: 15529390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bromocriptine for macroprolactinomas. Discussion of 3 cases treated successfully].
    Sapunar J; López JM; Huete I; Tagle R
    Rev Med Chil; 1992 Feb; 120(2):168-73. PubMed ID: 1340555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Misdiagnosis due to the hook effect in prolactin assay.
    Yener S; Comlekci A; Arda N; Men S; Yesil S
    Med Princ Pract; 2008; 17(5):429-31. PubMed ID: 18685288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long-acting and repeatable dose bromocriptine in the prolonged treatment of prolactinoma].
    Pereira JL; García-Luna PP; Leal-Cerro A; Cortés A; Trujillo F; Villamil F; Vaquero F; Revuelta M; Astorga R
    Med Clin (Barc); 1994 Jun; 103(2):59-64. PubMed ID: 8051973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prolactinoma in a child showing high MIB-1 labeling index: a case report].
    Akamine S; Miyamoto T; Sugiura Y; Takehara S; Hiramatsu H; Nishizawa S; Yokota N
    No Shinkei Geka; 2000 Jun; 28(6):547-53. PubMed ID: 10875113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
    Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
    Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of oxcarbamazepine on the clinical effectiveness of dopamine agonists in the treatment of prolactinoma].
    Krysiak R; Kedzia A; Okopień B
    Wiad Lek; 2011; 64(4):279-82. PubMed ID: 22533152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Campimetric alterations caused by pituitary microadenoma successfully treated by transsphenoidal adenomectomy.
    Madrazo-Navarro I; Maldonado-León JA
    Arch Invest Med (Mex); 1991; 22(1):9-12. PubMed ID: 1819982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Symptomatic episodic cluster headache as the first symptom of a prolactinoma].
    Soto-Cabrera E; Chávez-Valencia V; Zermeño-Pohls F; González-Aguilar A
    Rev Neurol; 2009 Aug 1-15; 49(3):165-6. PubMed ID: 19621313
    [No Abstract]   [Full Text] [Related]  

  • 34. [Alternative to bromocriptine (BEC) management in patients with prolactinoma and intolerance to oral BEC].
    Fletes Rabago VM; Torres Farias S; Domínguez Jiménez A; Padilla Ruiz R
    Ginecol Obstet Mex; 1991 Sep; 59():283-8. PubMed ID: 1797615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 22-year-old man with severe osteoporosis due to prolactinoma.
    Dandinoğlu T; Akarsu S; Tekin L; Arbal S; Dinçer U
    J Clin Rheumatol; 2013 Sep; 19(6):341-3. PubMed ID: 23965473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgery combined with dopamine agonists versus dopamine agonists alone in long-term treatment of macroprolactinoma: a retrospective study.
    Höfle G; Gasser R; Mohsenipour I; Finkenstedt G
    Exp Clin Endocrinol Diabetes; 1998; 106(3):211-6. PubMed ID: 9710362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of prolactinoma presenting with CSF rhinorrhea and CSF otorrhea during bromocriptine therapy].
    Nakajima T; Tamura T; Kuroki M; Tanaka R; Hayashi H
    No Shinkei Geka; 1992 Oct; 20(10):1091-5. PubMed ID: 1407345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Risk of prolactinoma growth during pregnancy. Visual field tests required in macroadenoma, small risk in microadenomas].
    Ericsson C; Lindblom B
    Lakartidningen; 2012 Jun 19-26; 109(25):1226-8. PubMed ID: 22838112
    [No Abstract]   [Full Text] [Related]  

  • 39. Surgical treatment for male prolactinoma: A retrospective study of 184 cases.
    Song YJ; Chen MT; Lian W; Xing B; Yao Y; Feng M; Wang RZ
    Medicine (Baltimore); 2017 Jan; 96(2):e5833. PubMed ID: 28079813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics of male prolactinoma patients mainly presenting with severe obesity and the metabolic response to dopamine agonist therapy.
    Wang L; Wang X; Gong F; Pan H; Zhu H
    Front Endocrinol (Lausanne); 2023; 14():1285477. PubMed ID: 38093965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.